Jeong-hoon Kim

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK.

Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK.

Journal: Journal of medicinal chemistry

Published: June 16, 2026

PINK1 and STUB1 pathway orchestrates peroxisomal selective autophagy by PEX13 depletion.

PINK1 and STUB1 pathway orchestrates peroxisomal selective autophagy by PEX13 depletion.

Journal: Cell death and differentiation

Published: August 23, 2025

Discovery of a novel molecular glue degrader targeting GSPT1/2 with a non-IMiD-based CRBN binder.

Discovery of a novel molecular glue degrader targeting GSPT1/2 with a non-IMiD-based CRBN binder.

Journal: European journal of medicinal chemistry

Published: January 14, 2025

Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers.

Discovery of novel WRN inhibitors for treating MSI-H colorectal cancers.

Journal: Bioorganic & medicinal chemistry letters

Published: January 06, 2025

Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle.

Design and evaluation of anaplastic lymphoma kinase degraders using a covalent fumarate handle.

Journal: Bioorganic & medicinal chemistry letters

Published: August 21, 2024

Histone lysine methylation modifiers controlled by protein stability.

Histone lysine methylation modifiers controlled by protein stability.

Journal: Experimental & molecular medicine

Published: March 28, 2024

Design of hypoxia responsive CRISPR-Cas9 for target gene regulation.

Design of hypoxia responsive CRISPR-Cas9 for target gene regulation.

Journal: Scientific reports

Published: March 08, 2023

CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells.

CDK9 inhibitors downregulate DKK1 expression to suppress the metastatic potential of HCC cells.

Journal: Genes & genomics

Published: October 26, 2022

Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells.

Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells.

Journal: Molecules and cells

Published: October 18, 2022

Hypoxia stabilizes SETDB1 to maintain genome stability.

Hypoxia stabilizes SETDB1 to maintain genome stability.

Journal: Nucleic acids research

Published: October 01, 2022

Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells.

Synergistic antitumor activity of sorafenib and MG149 in hepatocellular carcinoma cells.

Journal: BMB reports

Published: February 23, 2022

Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model.

Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model.

Journal: Bioorganic chemistry

Published: February 09, 2022

Showing 1-12 of 50

Last Updated: 09/26/2026